GT Biopharma
GT Biopharma reported $7,750,000 raised in an SEC Form D filed on 2026-09-29. State of the filing: California.
- Industry
- Biotechnology
- Location
- California
About
GT Biopharma appears in Section 3 of the Raise Track Update of 2026-09-30, which lists new SEC Form D filings. The filing reports $7,750,000 raised and gives California as the state. The industry on the filing is Biotechnology. Filing: https://www.sec.gov/Archives/edgar/data/109657/000010965726000001/0000109657-26-000001-index.htm
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-09-29 | $7.75M |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/109657/000010965726000001/0000109657-26-000001-index.htm
Type: sec filing. Accessed 2026-10-12.
SEC Form D filed 2026-09-29 by GT Biopharma, Inc. Reports $7,750,000 of securities sold. It does not name investors or a round type. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-09-30/
Type: other verified public source. Accessed 2026-10-12.
Raise Track Update for 2026-09-30, Section 3 (SEC Form D filings). Lists GT Biopharma, state CALIFORNIA, industry Biotechnology, amount raised $7,750,000.